| From oncogenic signaling pathways to single-cell sequencing of immune cells: changing the landscape of cancer immunotherapy A Derakhshani, Z Rostami, H Safarpour, MA Shadbad, NS Nourbakhsh, ... Molecules 26 (8), 2278, 2021 | 36 | 2021 |
| The regulatory role of autophagy-related miRNAs in lung cancer drug resistance M Shahverdi, K Hajiasgharzadeh, AD Sorkhabi, M Jafarlou, M Shojaee, ... Biomedicine & Pharmacotherapy 148, 112735, 2022 | 30 | 2022 |
| Evaluation of the Methylation of MIR129-2 Gene in Gastric Cancer N Alizadeh, M Asadi, D Shanehbandi, V Zafari, N Shomali, T Asvadi, ... Journal of Gastrointestinal Cancer 51, 267-270, 2020 | 24 | 2020 |
| The study of HLA-G gene and protein expression in patients with recurrent miscarriage E Mosaferi, NA Gharamaleki, L Farzadi, J Majidi, Z Babaloo, M Ramezani, ... Advanced Pharmaceutical Bulletin 9 (1), 70, 2019 | 21 | 2019 |
| A systematic review and meta-analysis on the significance of TIGIT in solid cancers: Dual TIGIT/PD-1 blockade to overcome immune-resistance in solid cancers N Hosseinkhani, MA Shadbad, M Asghari Jafarabadi, N Karim Ahangar, ... International Journal of Molecular Sciences 22 (19), 10389, 2021 | 18 | 2021 |
| Promising immunotherapy: Highlighting cytokine‐induced killer cells S Shirjang, N Alizadeh, B Mansoori, A Mahmoodpoor, HS Kafil, ... Journal of Cellular Biochemistry 120 (6), 8863-8883, 2019 | 18 | 2019 |
| The regulatory cross-talk between microRNAs and novel members of the B7 family in human diseases: a scoping review NK Ahangar, N Hemmat, M Khalaj-Kondori, MA Shadbad, H Sabaie, ... International Journal of Molecular Sciences 22 (5), 2652, 2021 | 15 | 2021 |
| miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene S Safaei, M Amini, S Najjary, A Mokhtarzadeh, N Bolandi, H Saeedi, ... Experimental and Molecular Pathology 125, 104753, 2022 | 13 | 2022 |
| Helicobacter pylori recombinant CagA regulates Th1/Th2 balance in a BALB/c murine model N Paydarnia, B Mansoori, D Esmaeili, T Kazemi, M Aghapour, ... Advanced Pharmaceutical Bulletin 10 (2), 264, 2020 | 13 | 2020 |
| Frequency of null allele of Human Leukocyte Antigen-G (HLA-G) locus in subjects to recurrent miscarriage N Alizadeh, E Mosaferi, L Farzadi, J Majidi, A Monfaredan, B Yousefi, ... International Journal of Reproductive BioMedicine 14 (7), 459, 2016 | 11 | 2016 |
| A systematic review of the tumor-infiltrating CD8+ T-Cells/PD-L1 axis in high-grade glial tumors: Toward personalized immuno-oncology MA Shadbad, Z Asadzadeh, N Hosseinkhani, A Derakhshani, N Alizadeh, ... Frontiers in immunology 12, 734956, 2021 | 10 | 2021 |
| CTLA-4: as an immunosuppressive immune checkpoint in breast cancer S Ghahremani Dehbokri, N Alizadeh, A Isazadeh, A Baghbanzadeh, ... Current Molecular Medicine 23 (6), 521-526, 2023 | 8 | 2023 |
| B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview K Dolatkhah, N Alizadeh, H Mohajjel‐Shoja, M Abdoli Shadbad, ... International Journal of Rheumatic Diseases 25 (3), 259-271, 2022 | 6 | 2022 |
| Silencing tumor-intrinsic HHLA2 potentiates the anti-tumoral effect of paclitaxel on MG63 cells: Another side of immune checkpoint NK Ahangar, M Khalaj-Kondori, N Alizadeh, A Mokhtarzadeh, ... Gene 855, 147086, 2023 | 5 | 2023 |
| The modulatory role of dendritic cell-T cell cross-talk in breast cancer: Challenges and prospects M Shahverdi, J Masoumi, F Ghorbaninezhad, N Shajari, F Hajizadeh, ... Advances in Medical Sciences 67 (2), 353-363, 2022 | 5 | 2022 |
| The clinical characteristics and treatment approaches of COVID-19: a concise review S Eslamkhah, N Alizadeh, K Hajiasgharzadeh, M Eslamkhah, ... Pharmaceutical Sciences 27 (Covid-19), S50-S67, 2021 | 4 | 2021 |
| Relation between HLA-G gene null allele (HLA-G* 0105n) and recurrent miscarriage N Alizadeh, J Majidi, A Movassaghpoor, L Farzadi, M Mohammadian, ... Shiraz E-Medical Journal 16 (3), 2015 | 4 | 2015 |
| Determination of sexual dimorphism from maxillary premolars thickness in bitewing radiography A GHODOUSI, R GHAFARI, N Alizadeh JOURNAL OF DENTISTRY (SHIRAZ UNIVERSITY OF MEDICAL SCIENCES) 9 (320), 213-221, 2008 | 4 | 2008 |
| Targeted therapy of B7 family checkpoints as an innovative approach to overcome cancer therapy resistance: a review from chemotherapy to immunotherapy B Amir Taghavi, N Alizadeh, H Saeedi, N Karim Ahangar, A Derakhshani, ... Molecules 27 (11), 3545, 2022 | 3 | 2022 |
| Oncogenic signaling pathways in cancer: an overview A Derakhshani, Z Rostami, S Taefehshokr, H Safarpour, RV Astamal, ... Preprints, 2020 | 3 | 2020 |
behzad baradaranImmunology Research Center, Tabriz University of Medical SciencesVerified email at tbzmed.ac.ir
